Mourad Tighiouart

14PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 31, 2026
L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial.

|Nov 17, 2025
A Bayesian design for dual-agent dose optimization with targeted therapies.

José L Jiménez, Mourad Tighiouart

|Apr 04, 2025
Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization Tool.

Gillian Gresham, Michael Luu, N Lynn Henry

|Sep 19, 2024
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Alice Y Ho, Stephen Shiao, Samantha A Kobald

|Aug 29, 2024
Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels.

Mourad Tighiouart, André Rogatko

|Mar 18, 2024
High-resolution Diffusion-weighted Imaging to Detect Changes in Tumor Size and ADC, and Predict Adverse Biopsy Histology during Prostate Cancer Active Surveillance.

Rola Saouaf, Yibin Xie, Sungjin Kim

Pageof 3

Frequent Collaborators

5 joint publications

André Rogatko

4 joint publications

Márcio A Diniz

4 joint publications

Greg Yothers

3 joint publications

Sungjin Kim